EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Blood Pharming of Red Cells

Romy Kronstein-Wiedemann, Desiree C Brändle, Stephan R Künzel, Torsten Tonn

Transfusion Medicine and Hemotherapy · 21.05.2026 · 1-15

DOI: 10.1159/000552465 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Transfusion Medicine and Hemotherapy, online erschienen am 21.05.2026. Verfasst von Romy Kronstein-Wiedemann und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Experimental Transfusion Medicine, Transfusion Medicine, Med. Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germ…. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The transfusion of blood is an indispensable and irreplaceable component of contemporary medicine. Nevertheless, particularly in patients with very rare blood groups, the lack of blood products still represents a significant health problem on a global scale. In order to address this shortage, strategies for producing artificial blood substitutes have been pursued for a period of time exceeding 60 years. Summary: This overview synthesizes the latest advancements in the field of erythropoiesis, encompassing the expansion strategies for erythrocyte cells, the diverse sources of ex vivo-expanded erythrocytes, the impediments to clinical implementation, the prospective applications, and alternative blood products.

Conclusions

Ex vivo generation of red blood cells (RBCs) has advanced from proof-of-concept to early clinical testing, yet scalable, cost-effective manufacturing remains unresolved. Continued optimization of cell sources, immortalized progenitor lines, and bioreactor technologies, alongside deeper mechanistic insights into terminal erythropoiesis and enucleation, will be key. Integrating these advances within rigorous regulatory frameworks could ultimately enable standardized, universally compatible RBC products.

Schlagwörter

Stichwörter der Autor:innen

Alternative blood productsErythropoiesisEx vivo expansionStem cellsTerminal differentiation

Autor:innen und Institutionen

  • Laboratory for Experimental Transfusion Medicine, Transfusion Medicine, Med. Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
  • Institute for Transfusion Medicine, German Red Cross Blood Donation Service North-East, Dresden, Germany.
  • Institute for Transfusion Medicine and Immunohematology, Goethe University Hospital Medical School, Frankfurt, Germany.
  • German Red Cross Blood Donor Service Baden-Wuerttemberg-Hessen, Frankfurt, Germany.

Zitieren

APA

Kronstein-Wiedemann, R., Brändle, D. C., Künzel, S. R., & Tonn, T. (2026). Blood Pharming of Red Cells. Transfusion Medicine and Hemotherapy, 1-15. https://doi.org/10.1159/000552465

Vancouver

Kronstein-Wiedemann R, Brändle DC, Künzel SR, Tonn T. Blood Pharming of Red Cells. Transfusion Medicine and Hemotherapy. 2026:1-15. doi:10.1159/000552465

BibTeX
@article{KronsteinWiedemann2026,
  author = {Kronstein-Wiedemann, Romy and Brändle, Desiree C and Künzel, Stephan R and Tonn, Torsten},
  title = {Blood Pharming of Red Cells},
  journal = {Transfusion Medicine and Hemotherapy},
  year = {2026},
  pages = {1--15},
  doi = {10.1159/000552465}
}
Kostenlos starten →